Midatech Pharma PLC - Company & Market Research Reports

Midatech Pharma is a specialty pharmaceutical company that focuses on the commercialization of oncology treatment and supportive care pharmaceutical products in the United States. The company's best known products are Soltamox, Gelclair, Bionect, Ferralet 90 and Aquoral. The Group has a wide IP portfolio of 82 granted patents, 81 applications in process and 30 patent families covering a range of technologies. Formerly known as DARA BioSciences, Midatech was incorporated in 2002 and is headquartered in Raleigh, North Carolina.

Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities - Product Thumbnail Image

Ocular Drug Delivery: Market Overview, Delivery Technologies, and Partnering Opportunities

  • Report
  • 144 Pages
United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices - Product Thumbnail Image

United Kingdom Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

  • Report
  • 260 Pages
From
Nanotechnology in Drug Delivery - Global Strategic Business Report - Product Thumbnail Image

Nanotechnology in Drug Delivery - Global Strategic Business Report

  • Report
  • 202 Pages
From
Uveitis - Pipeline Review, H2 2018 - Product Thumbnail Image

Uveitis - Pipeline Review, H2 2018

  • Drug Pipelines
  • 207 Pages
From
Uveitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Uveitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 195 Pages
From
Insulin Delivery - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Insulin Delivery - Medical Devices Pipeline Assessment, 2018

  • Report
  • 446 Pages
From
Peptide Therapeutics in Metabolic Disorders, 2016 - 2025 - Product Thumbnail Image

Peptide Therapeutics in Metabolic Disorders, 2016 - 2025

  • Report
  • 436 Pages
From
Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Acromegaly Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 83 Pages
From
Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Pipeline Review, H2 2016 - Product Thumbnail Image

Fatty Acid Amide Hydrolase (Oleamide Hydrolase 1 or Anandamide Amidohydrolase or FAAH or EC 3.5.1.99) - Pipeline Review, H2 2016

  • Drug Pipelines
  • 58 Pages
From
Nanomedicine - Global Strategic Business Report - Product Thumbnail Image

Nanomedicine - Global Strategic Business Report

  • Report
  • 698 Pages
From
Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016 - Product Thumbnail Image

Fatty Acid Amide Hydrolase (FAAH or Anandamide Amidohydrolase or EC 3.5.1.99) - Pipeline Review, H1 2016

  • Drug Pipelines
  • 59 Pages
From
Pontine Glioma (DIPG): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pontine Glioma (DIPG): Drug Development Pipeline Study, H1 2018

  • Report
  • 65 Pages
From
Neuroendocrine Tumors - Pipeline Review, H1 2017 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Review, H1 2017

  • Drug Pipelines
  • 422 Pages
From
Oral Proteins and Peptides Market (3rd Edition), 2018-2030 - Product Thumbnail Image

Oral Proteins and Peptides Market (3rd Edition), 2018-2030

  • Report
  • 421 Pages
From
Pain Management Devices - Medical Devices Pipeline Assessment, 2018 - Product Thumbnail Image

Pain Management Devices - Medical Devices Pipeline Assessment, 2018

  • Report
  • 300 Pages
From
Global Tamoxifen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025 - Product Thumbnail Image

Global Tamoxifen Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025

  • Report
From
Hepatocellular Carcinoma - Pipeline Review, H1 2018 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1275 Pages
From
Neuroendocrine Tumors - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Review, H2 2017

  • Drug Pipelines
  • 467 Pages
From
Hepatocellular Carcinoma - Pipeline Review, H2 2017 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1120 Pages
From
Liver Cancer - Pipeline Review, H2 2016 - Product Thumbnail Image

Liver Cancer - Pipeline Review, H2 2016

  • Drug Pipelines
  • 1171 Pages
From
Loading Indicator
adroll